Second, research is needed to discover and validate sensitive and specific biomarkers to guide management of anemia (e.g. timing of transfusion, optimal Hb cutoffs) in stratified subsets or individuals with ischemic stroke. This evidence concerns the gene GSTM1 and anemia (phenotype).